$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-K Financial Statement

#000117992915000007 Filed on February 26, 2015

Income Statement

Concept	2013 Q4	2013 Q3	2013 Q2
Revenue	$1.706B	$1.687B	$1.606B
YoY Change	8.09%	9.54%	8.56%
Cost Of Revenue	$1.457B	$1.423B	$1.334B
YoY Change	10.45%	4.89%	-1.05%
Gross Profit	$249.0M	$263.8M	$271.8M
YoY Change	-3.9%	44.0%	107.48%
Gross Profit Margin	14.6%	15.64%	16.93%
Selling, General & Admin	$231.4M	$220.0M	$208.4M
YoY Change	21.09%	33.41%	26.92%
% of Gross Profit	92.93%	83.4%	76.67%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.90M	$24.13M	$22.11M
YoY Change	26.34%	18.98%	12.39%
% of Gross Profit	10.4%	9.15%	8.13%
Operating Expenses	$251.7M	$238.9M	$225.4M
YoY Change	21.42%	32.13%	24.94%
Operating Profit	-$2.700M	$24.93M	$46.45M
YoY Change	-104.99%	952.62%	-193.96%
Interest Expense	-$13.80M	$13.53M	$11.67M
YoY Change	220.93%	213.6%	206.38%
% of Operating Profit		54.29%	25.12%
Other Income/Expense, Net	$0.00	-$13.51M	-$15.17M
YoY Change	-100.0%	200.24%	209.95%
Pretax Income	-$16.50M	$11.42M	$31.28M
YoY Change	-132.9%	-635.8%	-157.57%
Income Tax	-$7.500M	$3.865M	$15.48M
% Of Pretax Income		33.85%	49.5%
Net Earnings	-$9.126M	$7.569M	$24.57M
YoY Change	-135.59%	125.0%	-165.86%
Net Earnings / Revenue	-0.54%	0.45%	1.53%
Basic Earnings Per Share	-$0.20	$0.17	$0.54
Diluted Earnings Per Share	-$0.20	$0.16	$0.53
COMMON SHARES
Basic Shares Outstanding	45.76M shares	45.70M shares	45.45M shares
Diluted Shares Outstanding		47.06M shares	46.51M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.639B	$1.592B	$1.461B
YoY Change	43.94%	48.42%	36.31%
Cash & Equivalents	$936.0M	$856.6M	$742.7M
Short-Term Investments	$703.1M	$735.2M	$718.5M
Other Short-Term Assets	$42.48M	$50.06M	$47.82M
YoY Change	49.67%	66.86%	-15.67%
Inventory
Prepaid Expenses
Receivables	$298.9M	$294.0M	$213.8M
Other Receivables	$32.80M	$0.00	$0.00
Total Short-Term Assets	$2.040B	$1.966B	$1.745B
YoY Change	51.18%	49.6%	32.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$292.1M	$267.3M	$249.3M
YoY Change	31.9%	26.69%	20.73%
Goodwill	$230.7M	$230.8M	$153.2M
YoY Change	52.72%	52.75%
Intangibles
YoY Change
Long-Term Investments	$10.90M	$11.70M	$12.50M
YoY Change	-18.66%	-13.33%	-4.58%
Other Assets	$46.46M	$35.74M	$35.77M
YoY Change	136.8%	77.81%	-73.58%
Total Long-Term Assets	$948.3M	$958.9M	$835.1M
YoY Change	61.92%	61.77%	40.0%
TOTAL ASSETS
Total Short-Term Assets	$2.040B	$1.966B	$1.745B
Total Long-Term Assets	$948.3M	$958.9M	$835.1M
Total Assets	$2.988B	$2.925B	$2.580B
YoY Change	54.43%	53.38%	34.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$320.0M	$282.7M	$180.2M
YoY Change	73.91%	87.22%	32.4%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$182.0M	$109.0K	$0.00
YoY Change	15658.27%	-90.46%	-100.0%
Total Short-Term Liabilities	$1.294B	$1.045B	$707.2M
YoY Change	56.27%	25.66%	-15.72%
LONG-TERM LIABILITIES
Long-Term Debt	$602.9M	$770.1M	$761.5M
YoY Change	130.3%	195.57%	182.77%
Other Long-Term Liabilities	$26.35M	$25.15M	$23.94M
YoY Change	12.23%	13.8%	7.37%
Total Long-Term Liabilities	$26.35M	$25.15M	$23.94M
YoY Change	-90.76%	-91.1%	-91.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.294B	$1.045B	$707.2M
Total Long-Term Liabilities	$26.35M	$25.15M	$23.94M
Total Liabilities	$2.110B	$2.032B	$1.704B
YoY Change	83.08%	76.4%	45.41%
SHAREHOLDERS EQUITY
Retained Earnings	$553.1M	$562.3M	$554.7M
YoY Change	10.58%	18.48%
Common Stock	$340.8M	$332.0M	$324.4M
YoY Change	19.38%	18.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$0.00	$0.00
YoY Change	-100.0%
Treasury Stock Shares		0.000 shares	0.000 shares
Shareholders Equity	$892.9M	$892.8M	$876.4M
YoY Change
Total Liabilities & Shareholders Equity	$3.003B	$2.925B	$2.580B
YoY Change	55.2%	53.38%	34.55%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2013 Q2
OPERATING ACTIVITIES
Net Income	-$9.126M	$7.569M	$24.57M
YoY Change	-135.59%	125.0%	-165.86%
Depreciation, Depletion And Amortization	$25.90M	$24.13M	$22.11M
YoY Change	26.34%	18.98%	12.39%
Cash From Operating Activities	$78.40M	$223.4M	-$131.8M
YoY Change	-6.44%	697.86%	-171.09%
INVESTING ACTIVITIES
Capital Expenditures	-$33.60M	-$29.20M	-$24.00M
YoY Change	31.25%	52.08%	21.21%
Acquisitions
YoY Change
Other Investing Activities	$31.70M	-$80.40M	-$386.6M
YoY Change	39.04%	688.24%	-32316.67%
Cash From Investing Activities	-$1.900M	-$109.6M	-$410.6M
YoY Change	-32.14%	271.53%	2107.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$50.00M	$50.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.900M	0.000	115.7M
YoY Change	-514.29%	-100.0%	171.6%
NET CHANGE
Cash From Operating Activities	78.40M	223.4M	-131.8M
Cash From Investing Activities	-1.900M	-109.6M	-410.6M
Cash From Financing Activities	2.900M	0.000	115.7M
Net Change In Cash	79.40M	113.8M	-426.7M
YoY Change	-1.12%	-1072.65%	-303.77%
FREE CASH FLOW
Cash From Operating Activities	$78.40M	$223.4M	-$131.8M
Capital Expenditures	-$33.60M	-$29.20M	-$24.00M
Free Cash Flow	$112.0M	$252.6M	-$107.8M
YoY Change	2.38%	435.17%	-152.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q4	moh	Availableforsale Securities Continuous Unrealized Loss Position12 Monthsor Longer Aggregate Loss Accumulatedin Investments AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsorLongerAggregateLossAccumulatedinInvestments	598000	USD
CY2013	moh	Availableforsale Securities Continuous Unrealized Loss Position12 Monthsor Longer Numberof Securities AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsorLongerNumberofSecurities	57	Security
CY2014	moh	Availableforsale Securities Continuous Unrealized Loss Position12 Monthsor Longer Numberof Securities AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsorLongerNumberofSecurities	32	Security
CY2013Q4	moh	Availableforsale Securities Continuous Unrealized Loss Position Lessthan12 Months Aggregate Loss Accumulatedin Investments AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessthan12MonthsAggregateLossAccumulatedinInvestments	1316000	USD
CY2014Q4	moh	Availableforsale Securities Continuous Unrealized Loss Position Lessthan12 Months Aggregate Loss Accumulatedin Investments AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessthan12MonthsAggregateLossAccumulatedinInvestments	1439000	USD
CY2014	moh	Class Of Warrant Or Right Threshold Percentage Of Stock Price Trigger ClassOfWarrantOrRightThresholdPercentageOfStockPriceTrigger	0.00625
CY2014	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2013	moh	Availableforsale Securities Continuous Unrealized Loss Position Lessthan12 Months Numberof Securities AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessthan12MonthsNumberofSecurities	174	Security
CY2014	moh	Availableforsale Securities Continuous Unrealized Loss Position Lessthan12 Months Numberof Securities AvailableforsaleSecuritiesContinuousUnrealizedLossPositionLessthan12MonthsNumberofSecurities	416	Security
CY2012	moh	Business Combination Contingent Consideration Accrual BusinessCombinationContingentConsiderationAccrual	0	USD
CY2013	moh	Business Combination Contingent Consideration Accrual BusinessCombinationContingentConsiderationAccrual	59948000	USD
CY2014	moh	Business Combination Contingent Consideration Accrual BusinessCombinationContingentConsiderationAccrual	0	USD
CY2012Q4	moh	Capitation Claims Payable CapitationClaimsPayable	49066000	USD
CY2013Q4	moh	Capitation Claims Payable CapitationClaimsPayable	20267000	USD
CY2014Q4	moh	Capitation Claims Payable CapitationClaimsPayable	28150000	USD
CY2014	dei	Amendment Flag AmendmentFlag	false
CY2014	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2014	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014	dei	Document Period End Date DocumentPeriodEndDate	2014-12-31
CY2014	dei	Document Type DocumentType	10-K
CY2014	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2015Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49873000	shares
CY2014	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2014	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q2	dei	Entity Public Float EntityPublicFloat	1338400000	USD
CY2014	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
CY2014	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2014	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2012	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	5942000	USD
CY2013	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	22820000	USD
CY2014	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	27379000	USD
CY2013Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	20800000	USD
CY2014Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	7600000	USD
CY2013Q4	moh	Availableforsale Securities Continuous Unrealized Loss Position12 Monthsor Longer Aggregate Loss Accumulatedin Investments AvailableforsaleSecuritiesContinuousUnrealizedLossPosition12MonthsorLongerAggregateLossAccumulatedinInvestments	1049000	USD
CY2014Q4	moh	Classof Warrantor Right Stated Percentage ClassofWarrantorRightStatedPercentage	0.01125
CY2012	moh	Cost Of Services Amortization Of Capitalized Software CostOfServicesAmortizationOfCapitalizedSoftware	13489000	USD
CY2013	moh	Cost Of Services Amortization Of Capitalized Software CostOfServicesAmortizationOfCapitalizedSoftware	18207000	USD
CY2014	moh	Cost Of Services Amortization Of Capitalized Software CostOfServicesAmortizationOfCapitalizedSoftware	38573000	USD
CY2014	moh	Deferred Compensation Plan Deferral Percentage Of Basic Salary DeferredCompensationPlanDeferralPercentageOfBasicSalary	1
CY2014	moh	Deferred Compensation Plan Deferral Percentage Of Bonus DeferredCompensationPlanDeferralPercentageOfBonus	1
CY2013Q4	moh	Deferred Tax Assets Financing Arrangements DeferredTaxAssetsFinancingArrangements	-2162000	USD
CY2014Q4	moh	Deferred Tax Assets Financing Arrangements DeferredTaxAssetsFinancingArrangements	-210000	USD
CY2013Q4	moh	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Prepaid Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPrepaidExpenses	-5354000	USD
CY2014Q4	moh	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Prepaid Expenses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsPrepaidExpenses	-5920000	USD
CY2013Q4	moh	Deferred Tax Liabilities Deferred Compensation DeferredTaxLiabilitiesDeferredCompensation	-3404000	USD
CY2014Q4	moh	Deferred Tax Liabilities Deferred Compensation DeferredTaxLiabilitiesDeferredCompensation	-4405000	USD
CY2013Q4	moh	Deferred Tax Liabilities Operating Losses DeferredTaxLiabilitiesOperatingLosses	-2326000	USD
CY2014Q4	moh	Deferred Tax Liabilities Operating Losses DeferredTaxLiabilitiesOperatingLosses	-3138000	USD
CY2013Q4	moh	Deferred Tax Liabilities Reserve Liabilities DeferredTaxLiabilitiesReserveLiabilities	-1909000	USD
CY2014Q4	moh	Deferred Tax Liabilities Reserve Liabilities DeferredTaxLiabilitiesReserveLiabilities	-2017000	USD
CY2013Q4	moh	Deferred Tax Liabilities State Taxes DeferredTaxLiabilitiesStateTaxes	-7027000	USD
CY2014Q4	moh	Deferred Tax Liabilities State Taxes DeferredTaxLiabilitiesStateTaxes	-8157000	USD
CY2013Q4	moh	Deferred Tax Liabilities Unrealized Losses DeferredTaxLiabilitiesUnrealizedLosses	-286000	USD
CY2014Q4	moh	Deferred Tax Liabilities Unrealized Losses DeferredTaxLiabilitiesUnrealizedLosses	-181000	USD
CY2012	moh	Denominator For Basic Net Income Loss DenominatorForBasicNetIncomeLoss	46380000	shares
CY2013	moh	Denominator For Basic Net Income Loss DenominatorForBasicNetIncomeLoss	45717000	shares
CY2014	moh	Denominator For Basic Net Income Loss DenominatorForBasicNetIncomeLoss	46935000	shares
CY2012	moh	Denominator For Diluted Net Income Loss DenominatorForDilutedNetIncomeLoss	46999000	shares
CY2013	moh	Denominator For Diluted Net Income Loss DenominatorForDilutedNetIncomeLoss	46862000	shares
CY2014	moh	Denominator For Diluted Net Income Loss DenominatorForDilutedNetIncomeLoss	48340000	shares
CY2012	moh	Depreciation And Amortization Of Capitalized Software DepreciationAndAmortizationOfCapitalizedSoftware	42938000	USD
CY2013	moh	Depreciation And Amortization Of Capitalized Software DepreciationAndAmortizationOfCapitalizedSoftware	54837000	USD
CY2014	moh	Depreciation And Amortization Of Capitalized Software DepreciationAndAmortizationOfCapitalizedSoftware	75402000	USD
CY2012	moh	Depreciationand Amortization Continuing Operations DepreciationandAmortizationContinuingOperations	63114000	USD
CY2013	moh	Depreciationand Amortization Continuing Operations DepreciationandAmortizationContinuingOperations	72743000	USD
CY2014	moh	Depreciationand Amortization Continuing Operations DepreciationandAmortizationContinuingOperations	92917000	USD
CY2012	moh	Divestiture Of Business Decrease In Carrying Value Of Assets DivestitureOfBusinessDecreaseInCarryingValueOfAssets	30942000	USD
CY2013	moh	Divestiture Of Business Decrease In Carrying Value Of Assets DivestitureOfBusinessDecreaseInCarryingValueOfAssets	0	USD
CY2014	moh	Divestiture Of Business Decrease In Carrying Value Of Assets DivestitureOfBusinessDecreaseInCarryingValueOfAssets	0	USD
CY2012	moh	Divestiture Of Business Decrease In Carrying Value Of Liabilities DivestitureOfBusinessDecreaseInCarryingValueOfLiabilities	23527000	USD
CY2013	moh	Divestiture Of Business Decrease In Carrying Value Of Liabilities DivestitureOfBusinessDecreaseInCarryingValueOfLiabilities	0	USD
CY2014	moh	Divestiture Of Business Decrease In Carrying Value Of Liabilities DivestitureOfBusinessDecreaseInCarryingValueOfLiabilities	0	USD
CY2012	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Health Insurance Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent	0.000
CY2013	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Health Insurance Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent	0.000
CY2014	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Health Insurance Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseHealthInsurancePercent	0.229
CY2012	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	0.000
CY2013	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	0.024
CY2014	moh	Effective Income Tax Rate Reconciliation Nondeductible Expense Warrants Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseWarrantsPercent	0.000
CY2012	moh	Effective Income Tax Reconciliation Change In Fair Value Of Contingent Consideration EffectiveIncomeTaxReconciliationChangeInFairValueOfContingentConsideration	0.048
CY2013	moh	Effective Income Tax Reconciliation Change In Fair Value Of Contingent Consideration EffectiveIncomeTaxReconciliationChangeInFairValueOfContingentConsideration	-0.003
CY2014	moh	Effective Income Tax Reconciliation Change In Fair Value Of Contingent Consideration EffectiveIncomeTaxReconciliationChangeInFairValueOfContingentConsideration	0.000
CY2012Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	228799000	USD
CY2013Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	329609000	USD
CY2014Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	361237000	USD
CY2012	moh	Health Care Organization Direct Delivery Expense HealthCareOrganizationDirectDeliveryExpense	33920000	USD
CY2013	moh	Health Care Organization Direct Delivery Expense HealthCareOrganizationDirectDeliveryExpense	48288000	USD
CY2014	moh	Health Care Organization Direct Delivery Expense HealthCareOrganizationDirectDeliveryExpense	96196000	USD
CY2012	moh	Health Care Organization Direct Delivery Expense Per Member Per Month HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth	1.60
CY2013	moh	Health Care Organization Direct Delivery Expense Per Member Per Month HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth	2.14
CY2014	moh	Health Care Organization Direct Delivery Expense Per Member Per Month HealthCareOrganizationDirectDeliveryExpensePerMemberPerMonth	3.44
CY2014Q3	moh	Health Care Organization Estimated Assessment Fees HealthCareOrganizationEstimatedAssessmentFees	88600000	USD
CY2012	moh	Health Care Organization Expenses Capitation Costs HealthCareOrganizationExpensesCapitationCosts	552136000	USD
CY2013	moh	Health Care Organization Expenses Capitation Costs HealthCareOrganizationExpensesCapitationCosts	603938000	USD
CY2014	moh	Health Care Organization Expenses Capitation Costs HealthCareOrganizationExpensesCapitationCosts	748388000	USD
CY2012	moh	Health Care Organization Expenses Capitation Costs Per Member Per Month HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth	26.07
CY2013	moh	Health Care Organization Expenses Capitation Costs Per Member Per Month HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth	26.83
CY2014	moh	Health Care Organization Expenses Capitation Costs Per Member Per Month HealthCareOrganizationExpensesCapitationCostsPerMemberPerMonth	26.77
CY2012	moh	Health Care Organization Expenses Gross Per Member Per Month HealthCareOrganizationExpensesGrossPerMemberPerMonth	235.68
CY2013	moh	Health Care Organization Expenses Gross Per Member Per Month HealthCareOrganizationExpensesGrossPerMemberPerMonth	238.99
CY2014	moh	Health Care Organization Expenses Gross Per Member Per Month HealthCareOrganizationExpensesGrossPerMemberPerMonth	288.84
CY2012	moh	Health Care Organization Expenses Other Costs HealthCareOrganizationExpensesOtherCosts	145551000	USD
CY2013	moh	Health Care Organization Expenses Other Costs HealthCareOrganizationExpensesOtherCosts	181165000	USD
CY2014	moh	Health Care Organization Expenses Other Costs HealthCareOrganizationExpensesOtherCosts	285935000	USD
CY2012	moh	Health Care Organization Expenses Other Costs Per Member Per Month HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth	6.87
CY2013	moh	Health Care Organization Expenses Other Costs Per Member Per Month HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth	8.05
CY2014	moh	Health Care Organization Expenses Other Costs Per Member Per Month HealthCareOrganizationExpensesOtherCostsPerMemberPerMonth	10.22
CY2012	moh	Health Care Organization Expenses Servicing Cost HealthCareOrganizationExpensesServicingCost	3423751000	USD
CY2013	moh	Health Care Organization Expenses Servicing Cost HealthCareOrganizationExpensesServicingCost	3611529000	USD
CY2014	moh	Health Care Organization Expenses Servicing Cost HealthCareOrganizationExpensesServicingCost	5672483000	USD
CY2012	moh	Health Care Organization Expenses Servicing Cost Per Member Per Month HealthCareOrganizationExpensesServicingCostPerMemberPerMonth	161.67
CY2013	moh	Health Care Organization Expenses Servicing Cost Per Member Per Month HealthCareOrganizationExpensesServicingCostPerMemberPerMonth	160.43
CY2014	moh	Health Care Organization Expenses Servicing Cost Per Member Per Month HealthCareOrganizationExpensesServicingCostPerMemberPerMonth	202.87
CY2012	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	0	USD
CY2013	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	0	USD
CY2014	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	88591000	USD
CY2012	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	0	USD
CY2013	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	0	USD
CY2014	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	119484000	USD
CY2012	moh	Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth	39.47
CY2013	moh	Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth	41.54
CY2014	moh	Health Care Organization Medical Suppliesand Drugs Expense Per Member Per Month HealthCareOrganizationMedicalSuppliesandDrugsExpensePerMemberPerMonth	45.54
CY2012	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	158991000	USD
CY2013	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	172017000	USD
CY2014	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	294388000	USD
CY2012	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	15267000	USD
CY2013	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	28446000	USD
CY2014	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	470271000	USD
CY2014	moh	Investments Average Maturity Period InvestmentsAverageMaturityPeriod	P3Y
CY2014	moh	Investments Maturity Period InvestmentsMaturityPeriod	P10Y
CY2013Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	159394000	USD
CY2014Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	160710000	USD
CY2014	moh	Maturity Of Cash And Cash Equivalents MaturityOfCashAndCashEquivalents	three months or less
CY2014	moh	Maximum Period For Member Risk Scores And Member Pharmacy Cost Experience After Original Year Of Service MaximumPeriodForMemberRiskScoresAndMemberPharmacyCostExperienceAfterOriginalYearOfService	P2Y
CY2012	moh	Medical Administrative Costs MedicalAdministrativeCosts	125200000	USD
CY2013	moh	Medical Administrative Costs MedicalAdministrativeCosts	153000000	USD
CY2014	moh	Medical Administrative Costs MedicalAdministrativeCosts	262600000	USD
CY2013Q4	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	151300000	USD
CY2014Q4	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	119300000	USD
CY2012	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	-7004000	USD
CY2013	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	111267000	USD
CY2014	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	-31973000	USD
CY2013Q4	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	56922000	USD
CY2014Q4	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	527193000	USD
CY2012Q4	moh	Other Claims Payable OtherClaimsPayable	28858000	USD
CY2013Q4	moh	Other Claims Payable OtherClaimsPayable	180310000	USD
CY2014Q4	moh	Other Claims Payable OtherClaimsPayable	230531000	USD
CY2012	moh	Percentage Of Capitation PercentageOfCapitation	0.111
CY2013	moh	Percentage Of Capitation PercentageOfCapitation	0.112
CY2014	moh	Percentage Of Capitation PercentageOfCapitation	0.093
CY2012	moh	Percentage Of Fee For Service PercentageOfFeeForService	0.686
CY2013	moh	Percentage Of Fee For Service PercentageOfFeeForService	0.671
CY2014	moh	Percentage Of Fee For Service PercentageOfFeeForService	0.702
CY2012	moh	Percentage Of Medical Costs PercentageOfMedicalCosts	1
CY2013	moh	Percentage Of Medical Costs PercentageOfMedicalCosts	1
CY2014	moh	Percentage Of Medical Costs PercentageOfMedicalCosts	1
CY2012	moh	Percentage Of Other PercentageOfOther	0.029
CY2013	moh	Percentage Of Other PercentageOfOther	0.034
CY2014	moh	Percentage Of Other PercentageOfOther	0.035
CY2012	moh	Percentage Of Pharmacy PercentageOfPharmacy	0.167
CY2013	moh	Percentage Of Pharmacy PercentageOfPharmacy	0.174
CY2014	moh	Percentage Of Pharmacy PercentageOfPharmacy	0.158
CY2012	moh	Percentof Direct Delivery PercentofDirectDelivery	0.007
CY2013	moh	Percentof Direct Delivery PercentofDirectDelivery	0.009
CY2014	moh	Percentof Direct Delivery PercentofDirectDelivery	0.012
CY2012Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	38992000	USD
CY2013Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	45037000	USD
CY2014Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	71412000	USD
CY2012	moh	Premium Tax Expenses PremiumTaxExpenses	158991000	USD
CY2013	moh	Premium Tax Expenses PremiumTaxExpenses	172017000	USD
CY2014	moh	Premium Tax Expenses PremiumTaxExpenses	294388000	USD
CY2012	moh	Retirement Of Common Stock Used For Stock Based Compensation RetirementOfCommonStockUsedForStockBasedCompensation	11862000	USD
CY2013	moh	Retirement Of Common Stock Used For Stock Based Compensation RetirementOfCommonStockUsedForStockBasedCompensation	7711000	USD
CY2014	moh	Retirement Of Common Stock Used For Stock Based Compensation RetirementOfCommonStockUsedForStockBasedCompensation	8802000	USD
CY2012	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	0	USD
CY2013	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	55660000	USD
CY2014	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	0	USD
CY2014Q4	moh	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	2	Plan
CY2014	moh	Stock Issued During Period Valueand Income Tax Benefit Relatedto Sharebased Compensation StockIssuedDuringPeriodValueandIncomeTaxBenefitRelatedtoSharebasedCompensation	33200000	USD
CY2012	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	567000	shares
CY2013	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	400000	shares
CY2014	moh	Weighted Average Number Of Shares Issued Under Equity Offering WeightedAverageNumberOfSharesIssuedUnderEquityOffering	498000	shares
CY2012	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	0	shares
CY2013	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	0	shares
CY2014	moh	Weighted Average Numberof Shares Issued Exchangeof Debt Instruments WeightedAverageNumberofSharesIssuedExchangeofDebtInstruments	566000	shares
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	263043000	USD
CY2014Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	241654000	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	8987000	USD
CY2013Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	207934000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	277614000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1086000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1019000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	340848000	USD
CY2014Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	396059000	USD
CY2012	us-gaap	Adjustment For Amortization AdjustmentForAmortization	36200000	USD
CY2013	us-gaap	Adjustment For Amortization AdjustmentForAmortization	46400000	USD
CY2014	us-gaap	Adjustment For Amortization AdjustmentForAmortization	58700000	USD
CY2012	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	3100000	USD
CY2013	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	1600000	USD
CY2014	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	3000000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	21963000	USD
CY2012	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	3141000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	1602000	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	2989000	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	78997000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20018000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	28694000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21727000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	14556000	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	24501000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	14288000	USD
CY2012	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5942000	USD
CY2013	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	22103000	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	26064000	USD
CY2012	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20176000	USD
CY2013	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17906000	USD
CY2014	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17515000	USD
CY2013Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	608000000	USD
CY2014Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	859000000	USD
CY2012Q4	us-gaap	Assets Assets	1934822000	USD
CY2013Q4	us-gaap	Assets Assets	3002937000	USD
CY2014Q4	us-gaap	Assets Assets	4477215000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	2039664000	USD
CY2013Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	715702000	USD
CY2014Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1025951000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	3245397000	USD
CY2008Q1	us-gaap	Auction Rate Securities Noncurrent AuctionRateSecuritiesNoncurrent	82100000	USD
CY2014Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1024309000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	713950000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	613000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	395000	USD
CY2013Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2365000	USD
CY2014Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2037000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	306531000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	539475000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	44529000	USD
CY2014Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	47576000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	571971000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	570730000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	5100000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	4847000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	448880000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	448732000	USD
CY2014Q4	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	1024309000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Receivable CapitalLeasesFutureMinimumPaymentsReceivable	20441000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Receivable Current CapitalLeasesFutureMinimumPaymentsReceivableCurrent	4313000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Receivable Due Thereafter CapitalLeasesFutureMinimumPaymentsReceivableDueThereafter	2164000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Receivable In Five Years CapitalLeasesFutureMinimumPaymentsReceivableInFiveYears	1557000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Receivable In Four Years CapitalLeasesFutureMinimumPaymentsReceivableInFourYears	4116000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Receivable In Three Years CapitalLeasesFutureMinimumPaymentsReceivableInThreeYears	4256000	USD
CY2014Q4	us-gaap	Capital Leases Future Minimum Payments Receivable In Two Years CapitalLeasesFutureMinimumPaymentsReceivableInTwoYears	4035000	USD
CY2013Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	104016000	USD
CY2014Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	148453000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	493827000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	795770000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	935895000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1539063000	USD
CY2012	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	301943000	USD
CY2013	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	140125000	USD
CY2014	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	603168000	USD
CY2014Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	53.8475
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45871000	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49727000	shares
CY2013Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2014Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	10738000	USD
CY2013	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	52300000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	62290000	USD
CY2012	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2013	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	27211000	USD
CY2014	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	13841000	USD
CY2013Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	416368000	USD
CY2014Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	704097000	USD
CY2012	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	78764000	USD
CY2013	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	93866000	USD
CY2014	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	134404000	USD
CY2012	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	1571000	USD
CY2013	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	2914000	USD
CY2014	us-gaap	Cost Of Services Amortization CostOfServicesAmortization	2914000	USD
CY2012	us-gaap	Costs And Expenses CostsAndExpenses	5873116000	USD
CY2013	us-gaap	Costs And Expenses CostsAndExpenses	6452374000	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	9473684000	USD
CY2013Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	45675000	USD
CY2014Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	53675000	USD
CY2012	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	23019000	USD
CY2013	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	66883000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	72040000	USD
CY2012	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	24273000	USD
CY2013	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	67464000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	75078000	USD
CY2012	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1254000	USD
CY2013	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	581000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3038000	USD
CY2014	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2013Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	598240000	USD
CY2014Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	704097000	USD
CY2013Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	737000000	USD
CY2014Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	851551000	USD
CY2013Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	138760000	USD
CY2014Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	147454000	USD
CY2012	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9205000	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-25498000	USD
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	196076000	USD
CY2012	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4555000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-5650000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-2280000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	25976000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	15261000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-72000	USD
CY2012	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13760000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-31148000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2352000	USD
CY2013Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	122216000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	26556000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	39532000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-928000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-244000	USD
CY2013Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	-1323000	USD
CY2014Q4	us-gaap	Deferred Tax Assets State Taxes DeferredTaxAssetsStateTaxes	-134000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	2540000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	3800000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2087000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	5252000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	19545000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	13323000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1712000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	2487000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	10543000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Unearned Premiums Reserve DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve	21749000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	380000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	444000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3600000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5400000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	511000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	1042000	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance Noncurrent DeferredTaxAssetsValuationAllowanceNoncurrent	3084000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance Noncurrent DeferredTaxAssetsValuationAllowanceNoncurrent	4365000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	-466000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	14724000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	-27543000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	-34084000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	580000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	24271000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	24000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	96000	USD
CY2013Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	186239000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	40433000	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	57068000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	10700000	USD
CY2013	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12800000	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	21200000	USD
CY2014	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.04
CY2012	us-gaap	Depreciation Depreciation	20500000	USD
CY2013	us-gaap	Depreciation Depreciation	26600000	USD
CY2014	us-gaap	Depreciation Depreciation	34600000	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	63114000	USD
CY2013	us-gaap	Depreciation And Amortization DepreciationAndAmortization	72743000	USD
CY2014	us-gaap	Depreciation And Amortization DepreciationAndAmortization	92917000	USD
CY2012	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	590000	USD
CY2013	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	2000	USD
CY2014	us-gaap	Depreciation And Amortization Discontinued Operations DepreciationAndAmortizationDiscontinuedOperations	0	USD
CY2012	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	78764000	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	93866000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	134404000	USD
CY2013Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	186351000	USD
CY2014Q4	us-gaap	Derivative Assets Noncurrent DerivativeAssetsNoncurrent	329323000	USD
CY2012	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1307000	USD
CY2013	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3378000	USD
CY2014	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	17000	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	329194000	USD
CY2012	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-1238000	USD
CY2013	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-9912000	USD
CY2014	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	-203000	USD
CY2013Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	27092000	USD
CY2014Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	40241000	USD
CY2012	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.65
CY2013Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2013Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.16
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.34
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.70
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.33
CY2012	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2013Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.53
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2013Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.13
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.29
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.450
CY2013	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.448
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.538
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2013	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Charitable Contributions EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions	0.042
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Charitable Contributions EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions	0.016
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Charitable Contributions EffectiveIncomeTaxRateReconciliationNondeductibleExpenseCharitableContributions	-0.003
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.062
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.096
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.041
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.033
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.007
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.000
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.092
CY2013	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.005
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.004
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	0.007
CY2013	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.037
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Contingencies EffectiveIncomeTaxRateReconciliationTaxContingencies	-0.001
CY2012	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
CY2013	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	332000	USD
CY2014	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
CY2013Q4	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	374000000	USD
CY2014Q4	us-gaap	Fair Value Concentration Of Risk Investments FairValueConcentrationOfRiskInvestments	321000000	USD
CY2012	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2013	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	121801000	USD
CY2014	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	52057000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	139077000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	159506000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	16300000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9200000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	13800000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14100000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14400000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	237948000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	248779000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	98871000	USD
CY2014Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	89273000	USD
CY2012	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1747000	USD
CY2013	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2014	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
CY2012	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	1747000	USD
CY2013	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	0	USD
CY2014	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	0	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	518615000	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	665996000	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	764693000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	230738000	USD
CY2014Q4	us-gaap	Goodwill Goodwill	271964000	USD
CY2013Q4	us-gaap	Goodwill Gross GoodwillGross	289268000	USD
CY2014Q4	us-gaap	Goodwill Gross GoodwillGross	330494000	USD
CY2013Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	58530000	USD
CY2014Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	58530000	USD
CY2012	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2014	us-gaap	Goodwill Other Changes GoodwillOtherChanges	41226000	USD
CY2012	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	4991188000	USD
CY2013	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	5380124000	USD
CY2014	us-gaap	Health Care Organization Health Care Costs Gross HealthCareOrganizationHealthCareCostsGross	8076331000	USD
CY2012	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	835830000	USD
CY2013	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	935204000	USD
CY2014	us-gaap	Health Care Organization Medical Supplies And Drugs Expense HealthCareOrganizationMedicalSuppliesAndDrugsExpense	1273329000	USD
CY2012	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	18312000	USD
CY2013	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	26322000	USD
CY2014	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	12074000	USD
CY2012	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	5544121000	USD
CY2013Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1497433000	USD
CY2013Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1501729000	USD
CY2013Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1584656000	USD
CY2013Q4	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1595352000	USD
CY2013	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	6179170000	USD
CY2014Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1940337000	USD
CY2014Q2	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2167142000	USD
CY2014Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2316759000	USD
CY2014Q4	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2598273000	USD
CY2014	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	9022511000	USD
CY2014Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	102479000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1462000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	1462000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	101022000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	101017000	USD
CY2013	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-39262000	USD
CY2014	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	41729000	USD
CY2014Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	102484000	USD
CY2012	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12866000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	30522000	USD
CY2013Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	15796000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7553000	USD
CY2013Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9041000	USD
CY2013	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	44830000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	4834000	USD
CY2014Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7741000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	16070000	USD
CY2014Q4	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	33933000	USD
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	62578000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	23379000	USD
CY2013	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	81146000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	135304000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.28
CY2013	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.98
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.34
CY2012	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.27
CY2013	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.96
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.30
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-3076000	USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-607000	USD
CY2013Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8775000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	16000	USD
CY2013Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-85000	USD
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8099000	USD
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-336000	USD
CY2014Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	70000	USD
CY2014Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	52000	USD
CY2014Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-141000	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-355000	USD
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.07
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.18
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2012	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.06
CY2013	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.17
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10513000	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	36316000	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	72726000	USD
CY2013Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	32742000	USD
CY2014Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	0	USD
CY2012	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-4634000	USD
CY2013	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	95240000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	30413000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8078000	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	32550000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11097000	USD
CY2012	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	18172000	USD
CY2012	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	9887000	USD
CY2013	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	31047000	USD
CY2014	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	2352000	USD
CY2012	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	90851000	USD
CY2013	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-19582000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	73860000	USD
CY2012	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	92054000	USD
CY2013	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	175257000	USD
CY2014	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	530735000	USD
CY2012	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	13523000	USD
CY2013	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-5739000	USD
CY2014	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	22446000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8958000	USD
CY2013	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	23064000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	19517000	USD
CY2012	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-18216000	USD
CY2013	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	149253000	USD
CY2014	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	297521000	USD
CY2012	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	2647000	USD
CY2013	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	18992000	USD
CY2014	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	33661000	USD
CY2012	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	502000	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	907000	shares
CY2012	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	619000	shares
CY2013	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	643000	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	498000	shares
CY2012	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	5075000	USD
CY2013	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	6890000	USD
CY2014	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	8093000	USD
CY2012	us-gaap	Interest Expense InterestExpense	16769000	USD
CY2013	us-gaap	Interest Expense InterestExpense	52071000	USD
CY2014	us-gaap	Interest Expense InterestExpense	56811000	USD
CY2012	us-gaap	Interest Expense Debt InterestExpenseDebt	12954000	USD
CY2013	us-gaap	Interest Expense Debt InterestExpenseDebt	34530000	USD
CY2014	us-gaap	Interest Expense Debt InterestExpenseDebt	38568000	USD
CY2012	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7012000	USD
CY2013	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	12427000	USD
CY2014	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	12504000	USD
CY2012	us-gaap	Interest Paid InterestPaid	10099000	USD
CY2013	us-gaap	Interest Paid InterestPaid	34881000	USD
CY2014	us-gaap	Interest Paid InterestPaid	29178000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	2110000000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	3466773000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3002937000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4477215000	USD
CY2013Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	669787000	USD
CY2014Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1200522000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	4689395000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	4932195000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	7064427000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	308307000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	385479000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1293976000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2174773000	USD
CY2011Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	402476000	USD
CY2012Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	494530000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	449771000	USD
CY2012Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	377614000	USD
CY2013Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	424173000	USD
CY2014Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	870429000	USD
CY2012	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	5096760000	USD
CY2013	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	5381664000	USD
CY2014	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	8076906000	USD
CY2014Q4	us-gaap	Long Term Debt LongTermDebt	851551000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	182008000	USD
CY2014Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	341000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	851551000	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2014Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2013Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	703052000	USD
CY2014Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1019462000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	47743000	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	493353000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	78640000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-93584000	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-543311000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-535729000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	347784000	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	190083000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1060257000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	9790000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	29915000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	24571000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	7569000	USD
CY2013Q4	us-gaap	Net Income Loss NetIncomeLoss	-9126000	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	52929000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	4498000	USD
CY2014Q2	us-gaap	Net Income Loss NetIncomeLoss	7811000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	16122000	USD
CY2014Q4	us-gaap	Net Income Loss NetIncomeLoss	33792000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	62223000	USD
CY2012	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2013	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2014	us-gaap	Notes Issued1 NotesIssued1	176551000	USD
CY2014	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	41093000	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	136560000	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	192917000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	605385000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	45885000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	31716000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	38660000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	39408000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	40256000	USD
CY2014Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	409460000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	20500000	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	24500000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	32400000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	42484000	USD
CY2014Q4	us-gaap	Other Assets Current OtherAssetsCurrent	50884000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	46462000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	44326000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	100000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	948000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-629000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	67000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	581000	USD
CY2013	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-386000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	41000	USD
CY2012	us-gaap	Other Expenses OtherExpenses	945000	USD
CY2013	us-gaap	Other Expenses OtherExpenses	3343000	USD
CY2014	us-gaap	Other Expenses OtherExpenses	802000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	26351000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	33487000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17714000	USD
CY2013	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-55414000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-57613000	USD
CY2012	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	11224000	USD
CY2013	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	17729000	USD
CY2014	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6222000	USD
CY2012	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2013	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	149331000	USD
CY2014	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2012	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	4997702000	USD
CY2013	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	5317674000	USD
CY2014	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	7514198000	USD
CY2012	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3000000	USD
CY2013	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	52662000	USD
CY2014	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2012	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
CY2013	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	0	USD
CY2014	us-gaap	Payments To Acquire Business Two Net Of Cash Acquired PaymentsToAcquireBusinessTwoNetOfCashAcquired	50349000	USD
CY2012	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2013	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	61521000	USD
CY2014	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	44133000	USD
CY2012	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	78145000	USD
CY2013	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	98049000	USD
CY2014	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	114934000	USD
CY2012	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	306437000	USD
CY2013	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	770083000	USD
CY2014	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	953355000	USD
CY2012	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	4991188000	USD
CY2013	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	5380124000	USD
CY2014	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	8076331000	USD
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	9162000	USD
CY2013	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2014	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2012	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	9162000	USD
CY2013	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0	USD
CY2014	us-gaap	Proceeds From Divestiture Of Interest In Consolidated Subsidiaries ProceedsFromDivestitureOfInterestInConsolidatedSubsidiaries	0	USD
CY2012	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	537973000	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	122625000	USD
CY2012	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	8205000	USD
CY2013	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	9402000	USD
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	14040000	USD
CY2012	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2013	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	75074000	USD
CY2014Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	596456000	USD
CY2013Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	63093000	USD
CY2014	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
CY2012	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	60000000	USD
CY2013	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2014	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2012	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	3667000	USD
CY2013	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	1674000	USD
CY2014	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2773000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	298006000	USD
CY2013	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	399595000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	632800000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	500017000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	618392000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	292083000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	340778000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	103918000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	129161000	USD
CY2013Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	298935000	USD
CY2012	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2013	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	USD
CY2014	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	10449000	USD
CY2012	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1129000	USD
CY2013	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	47471000	USD
CY2014	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2012	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	20000000	USD
CY2013	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40000000	USD
CY2014	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2013Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	365200000	USD
CY2014Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	202600000	USD
CY2014Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	102479000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	553129000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	615352000	USD
CY2012	us-gaap	Revenues Revenues	5914209000	USD
CY2013	us-gaap	Revenues Revenues	6588934000	USD
CY2014	us-gaap	Revenues Revenues	9666601000	USD
CY2012	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	0	USD
CY2013	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	158694000	USD
CY2014	us-gaap	Sale Leaseback Transaction Gross Proceeds Financing Activities SaleLeasebackTransactionGrossProceedsFinancingActivities	0	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	20018000	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	28694000	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	21727000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	221698	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.26
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2000000	USD
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.97
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.67
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	7640000	USD
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	379221	shares
CY2012	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2013	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1200000	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2100000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	256698	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.14
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.77
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	7640000	USD
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	256698	shares
CY2014Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	23.77
CY2014	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	24.93
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	221698	shares
CY2014Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	256698	shares
CY2014Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	6932000	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y4M
CY2011Q4	us-gaap	Shares Outstanding SharesOutstanding	45815000	shares
CY2012Q4	us-gaap	Shares Outstanding SharesOutstanding	46762000	shares
CY2013Q4	us-gaap	Shares Outstanding SharesOutstanding	45871000	shares
CY2014Q4	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Estimated Range Of Change Upper Bound SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleEstimatedRangeOfChangeUpperBound	100000	USD
CY2014Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	955000000	USD
CY2014Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	541000000	USD
CY2012	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	277400	shares
CY2013	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	299600	shares
CY2014	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	327200	shares
CY2014	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	122523	shares
CY2014	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	22000000	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16362000	USD
CY2013	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30386000	USD
CY2014	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30263000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	892937000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	1010442000	USD
CY2011Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	755073000	USD
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	782314000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	892937000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1010442000	USD
CY2014	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	117500000	USD
CY2014	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	7924000	USD
CY2012	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	5136055000	USD
CY2013	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	5434443000	USD
CY2013	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-52779000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	5960000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	2084000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	777000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	441000	USD
CY2014	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	8122885000	USD
CY2012	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-39295000	USD
CY2014	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-45979000	USD
CY2014Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	12500000	USD
CY2014Q4	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	5400000	USD
CY2012	us-gaap	Technology Services Costs TechnologyServicesCosts	141208000	USD
CY2013	us-gaap	Technology Services Costs TechnologyServicesCosts	161494000	USD
CY2014	us-gaap	Technology Services Costs TechnologyServicesCosts	156764000	USD
CY2012	us-gaap	Technology Services Revenue TechnologyServicesRevenue	187710000	USD
CY2013Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	49756000	USD
CY2013Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	49672000	USD
CY2013Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	51100000	USD
CY2013Q4	us-gaap	Technology Services Revenue TechnologyServicesRevenue	54007000	USD
CY2013	us-gaap	Technology Services Revenue TechnologyServicesRevenue	204535000	USD
CY2014Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	53630000	USD
CY2014Q2	us-gaap	Technology Services Revenue TechnologyServicesRevenue	50232000	USD
CY2014Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	52557000	USD
CY2014Q4	us-gaap	Technology Services Revenue TechnologyServicesRevenue	53632000	USD
CY2014	us-gaap	Technology Services Revenue TechnologyServicesRevenue	210051000	USD
CY2012	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3000000	USD
CY2013	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	52662000	USD
CY2012	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1529000	USD
CY2013	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-1015000	USD
CY2014	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	108000	USD
CY2011Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10712000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10622000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	8030000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2594000	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	886000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	320000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	3615000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2013	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2014	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2012	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	211000	USD
CY2013	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	175000	USD
CY2014	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	253000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7400000	USD
CY2013Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	5700000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1600000	USD
CY2014	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	1800000	USD
CY2012	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46999000	shares
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46862000	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48340000	shares
CY2012	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	2000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1445000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
CY2012	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46380000	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45717000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46935000	shares
CY2014	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Concentrations of Credit Risk</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, investments, receivables, and restricted investments. We invest a substantial portion of our cash in the PFM Funds Prime Series — Institutional Class, and the PFM Funds Government Series. These funds represent a portfolio of highly liquid money market securities that are managed by PFM Asset Management LLC (PFM), a Virginia business trust registered as an open-end management investment fund. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2014</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2013</font><font style="font-family:inherit;font-size:10pt;">, our investments with PFM amounted to approximately </font><font style="font-family:inherit;font-size:10pt;">$321 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$374 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Our investments and a portion of our cash equivalents are managed by professional portfolio managers operating under documented investment guidelines. No investment that is in a loss position can be sold by our managers without our prior approval. Our investments consist solely of investment grade debt securities with a maximum maturity of </font><font style="font-family:inherit;font-size:10pt;">10</font><font style="font-family:inherit;font-size:10pt;"> years and an average duration of </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years or less. Restricted investments are invested principally in certificates of deposit and U.S. treasury securities. Concentration of credit risk with respect to accounts receivable is limited due to payors consisting principally of the governments of each state in which our health plan subsidiaries operate.</font></div></div>
CY2014	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated. </font></div><div style="line-height:120%;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td width="59%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td><td width="11%" rowspan="1" colspan="1"></td><td width="1%" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2013</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">2012</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="11" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In thousands)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">870,429</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">424,173</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">377,614</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">71,412</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45,037</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">38,992</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,150</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">20,267</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">49,066</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">230,531</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">180,310</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,858</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,200,522</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">669,787</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">494,530</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>
CY2014	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements. Estimates also affect the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. Principal areas requiring the use of estimates include:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health plan contractual provisions that may limit revenue recognition based upon the costs incurred or the profits realized under a specific contract;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health plan quality incentives that allow us to recognize incremental revenue if certain quality standards are met;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of medical claims and benefits payable of our Health Plans segment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The valuation of certain investments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Settlements under risk or savings sharing programs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The assessment of deferred contract costs, deferred revenue, long-lived and intangible assets, and goodwill for impairment;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of professional and general liability claims, and reserves for potential absorption of claims unpaid by insolvent providers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of reserves for the outcome of litigation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of valuation allowances for deferred tax assets; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The determination of unrecognized tax benefits.</font></div></td></tr></table></div>

Files In Submission

Name	View Source	Status
0001179929-15-000007-index-headers.html	Edgar Link	pending
0001179929-15-000007-index.html	Edgar Link	pending
0001179929-15-000007.txt	Edgar Link	pending
0001179929-15-000007-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
moh-12312014x10k.htm	Edgar Link	pending
moh-12312014x10kex104.htm	Edgar Link	pending
moh-12312014x10kex106.htm	Edgar Link	pending
moh-12312014x10kex121.htm	Edgar Link	pending
moh-12312014x10kex211.htm	Edgar Link	pending
moh-12312014x10kex231.htm	Edgar Link	pending
moh-12312014x10kex311.htm	Edgar Link	pending
moh-12312014x10kex312.htm	Edgar Link	pending
moh-12312014x10kex321.htm	Edgar Link	pending
moh-12312014x10kex322.htm	Edgar Link	pending
moh-20141231.xml	Edgar Link	completed
moh-20141231.xsd	Edgar Link	pending
moh-20141231_cal.xml	Edgar Link	unprocessable
moh-20141231_def.xml	Edgar Link	unprocessable
moh-20141231_lab.xml	Edgar Link	unprocessable
moh-20141231_pre.xml	Edgar Link	unprocessable
molinagraph14.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2013 Q4 Form 10-K Financial Statement

#000117992915000007 Filed on February 26, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2013 Q4 Form 10-K Financial Statement

#000117992915000007 Filed on February 26, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh